As a result of Medicare reform in recent years, the Prescription Drug Benefit, and the increasing cost of healthcare, the landscape is evolving at an alarming rate. As the biopharmaceutical industry continues to experience an increasing level of scrutiny from the government and public sectors, the medical industry will be significantly impacted in the future by legislative initiatives and high-level policy changes. By monitoring state and federal legislation and policy, the Palomino Group helps its clients pilot their way through this ever-changing world of healthcare reimbursement.
By maintaining relationships with top healthcare policy-makers and key opinion leaders (KOLs) within the medical community, we continually keep abreast of what is happening on the Hill. The Palomino Group has established strong relationships with leading policy-makers and is able to interpret and relay pertinent information back to our clients on an immediate basis. Our Legislative and Policy Monitoring service can be tailored to the specific needs of each client according to the frequency and level of support required.